Aura Biosciences, Inc.
AURA
DELAYED 1 MONTH

8 insider filings · Latest: May 19, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 7, 2026May 11 8:16 PMMatrix Capital Management Company, LP10% Owner
Sale
6,922,870$5.64$39.0M0(I)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 19, 2026May 19 8:59 PMNatalie C. HollesDirector, Chief Executive Officer and President
Grant/Award
2,169,103$7.392,169,103(D)

View →

Mar 2, 2026Mar 3 9:06 PMConor KilroyChief Legal Officer and Secretary
Grant/Award
112,661$6.14112,661(D)

View →

Mar 2, 2026Mar 3 9:06 PMAnthony S GibneyChief Financial and Business Officer
Grant/Award
128,755$6.14128,755(D)

View →

Mar 2, 2026Mar 3 9:06 PMLos Pinos Elisabet deDirector, President and Chief Executive Officer
Grant/Award
249,000$6.14249,000(D)

View →

Mar 2, 2026Mar 3 9:05 PMMark PlavsicChief Technology Officer
Grant/Award
112,661$6.14112,661(D)

View →

Mar 2, 2026Mar 3 9:05 PMJanet Jill HopkinsChief Medical Officer
Grant/Award
160,944$6.14160,944(D)

View →

Mar 2, 2026Mar 3 9:05 PMAmy ElazzouziSenior Vice President, Finance
Grant/Award
80,472$6.1480,472(D)

View →